SciELO - Scientific Electronic Library Online

 
vol.36 número8La indicación de la traqueotomía condiciona las variables predictoras del tiempo hasta la decanulación en pacientes críticosEl tratamiento antiagregante se asocia a un aumento del tamaño del hematoma y de la mortalidad en la hemorragia intracraneal índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Medicina Intensiva

versión impresa ISSN 0210-5691

Resumen

NAVAS, A. et al. Renal replacement therapy in the critical patient: treatment variation over time. Med. Intensiva [online]. 2012, vol.36, n.8, pp.540-547. ISSN 0210-5691.  https://dx.doi.org/10.1016/j.medin.2012.01.005.

Objectives: To analyze the evolution of patients subjected to renal replacement therapy (RRT), andto determine risk factorsassociated with mortality and the recovery of renal function. Design: A prospective, observational study of critically ill patients. Setting: Clinical-surgical Intensive Care Unit (ICU) of Sabadell Hospital (Spain). Patients: Inclusion of all patients treated in our Unit due to acute renal failure (ARF) requiring RRT. Primary variables of interest: We recorded epidemiological data, severity using the APACHE II score, days of the technique, ICU mortality, and renal function recovery. The study period was divided into 2 parts: part 1 (2000-2004) and part 2 (2005-2009). The 2 periods were compared using the Student t-test for continuous variables and the chi-squared test for categorical variables. Multiple regression analysis was performed to determine the risk factors for mortality and recovery of renal function. Results: A total of 304 patients were treated. Sepsis was the main etiology of ARF (61%), involving principally respiratory and abdominal foci. In the second period the convective technique and community-acquired ARF were far more prevalent than in the first period. There were fewer days of therapy in the second period (19.7 versus 12.3 days; P=.015). Total ICU mortality was 52.3%, with a decrease in the last period (61.9% to 45.5%: P=.003). The risk factors associated to mortality were creatinine upon admission (odds ratio [OR] 0.77; 95% confidence interval [95%CI] 0.61-0.97) and treatment with IHD alone (OR 0.37, 95%CI 0.16-0.87). Survivors had normal renal function at ICU discharge in 56.7% of the cases in the second period, vs in 72.9% in the first period, with more patients subjected to IHD in the second period (10.4% versus 26.8%). The factors related to the recovery of renal function were creatinine upon admission (OR 1.98, 95%CI 1.12-3.48), acute renal failure (OR 0.11, 95%CI 0.04-0.34) and treatment with continuous techniques (OR 0.18, 95%CI 0.03-0.85). Conclusions: Mortality among critically ill patients subjected to RRT has improved in recent years.

Palabras clave : Renal replacement therapy; Intermittent hemodialysis; Hemofiltration; Septic shock.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons